Endocrinology Conditions A Flashcards
Diabetes Mellitus Type 1 - Description
decreased insulin secretion
Diabetes Mellitus Type 1 - Causes (1)
1) autoimmunity (90% of HLA-DR3/HLA-DR4)
Diabetes Mellitus Type 1 - Pathophysiology (2)
1) autoimmune destruction of β cells in pancreas islet of Langerhans
2) decreased insulin secretion
Diabetes Mellitus Type 1 - Symptoms (6)
1) polyuria*
2) polydipsia*
3) weight loss
4) hunger
5) fatigue
6) blurred vision
Diabetes Mellitus Type 1 - Signs (4)
1) acute onset (<1 month)
2) ketosis (pear drop breath)
3) Caucasian
4) child/adolescent (esp. 5-15)
Diabetes Mellitus Type 1 - Complications (9)
1) vascular disease
2) nephropathy
3) neuropathy (30% painful)
4) retinopathy
5) cataracts
6) diabetic ketoacidosis (uncontrolled)
7) hypoglycaemia (iatrogenic)
8) infection (e.g. thrush, UTI)
9) autoimmune associations (e.g. Hashimoto’s thyroiditis, Addison’s disease, Coeliac disease)
Diabetes Mellitus Type 1 - Investigations (2/2)
initial 1) random plasma glucose* (>11mM) 2) Hb1Ac (>48mmol/mol, >6.5%) consider 1) fasting plasma glucose (>7mM) (follow-up) 2) glucose tolerance test (rarely used)
Diabetes Mellitus Type 1 - Management (6/4/0)
conservative 1) dietary advice 2) smoking cessation 3) alcohol control 4) regular exercise 5) monitor glucose 6) monitor Hb1Ac medical 1) basal-bolus insulin (1st line) 2) pre-meal insulin (adjunct) 3) pre-meal amylin (adjunct) 4) fixed-dose insulin (2nd line)
Diabetes Mellitus Type 2 - Description
decreased insulin secretion and efficacy
Diabetes Mellitus Type 2 - Risk Factors (10)
1) family history
2) Afro-Caribbean
3) Hispanic
4) Asian
5) old age
6) obesity
7) physical inactivity
8) pre-diabetes
9) gestational diabetes
10) hypertension
Diabetes Mellitus Type 2 - Pathophysiology (4)
1) dysfunction of β cells in pancreas islet of Langerhans
2) decreased insulin secretion
3) peripheral resistance to insulin
4) decreased insulin efficacy
Diabetes Mellitus Type 2 - Symptoms (3)
1) asymptomatic*
2) fatigue
3) blurred vision
Diabetes Mellitus Type 2 - Complications (7)
1) vascular disease
2) nephropathy
3) neuropathy (30% painful)
4) retinopathy
5) cataracts
6) hypoglycaemia (iatrogenic)
7) infection (e.g. thrush, UTI)
Diabetes Mellitus Type 2 - Investigations (2/2)
initial 1) random plasma glucose* (>11mM) 2) Hb1Ac (>48mmol/mol, >6.5%) consider 1) fasting plasma glucose (>7mM) (follow-up) 2) glucose tolerance test (rarely used)
Diabetes Mellitus Type 2 - Management (6/3/0)
conservative 1) dietary advice 2) smoking cessation 3) alcohol control 4) regular exercise 5) monitor plasma glucose 6) monitor Hb1Ac medical 1) metformin* 2) statin 3) antihypertensive (e.g. thiazide diuretic)
Diabetes Mellitus Type 2 - Management (Failed Hb1Ac Targets) (6)
1) pioglitazone
2) sulfonylurea
1) GLP-1 receptor agonist
4) SGLT-2 inhibitor
5) DPP-4 inhibitor
6) insulin (last resort)
Diabetic Ketoacidosis - Description
increased plasma ketone bodies
Diabetic Ketoacidosis - Risk Factors (3)
1) uncontrolled diabetes mellitus (esp. type 1)
2) infection
3) myocardial infarction
Diabetic Ketoacidosis - Pathophysiology (5)
1) decreased insulin secretion
2) increased lipolysis
3) increased hepatic fatty acid metabolism
4) increased plasma ketone bodies
5) decreased plasma pH
Diabetic Ketoacidosis - Symptoms (8)
1) polyuria
2) polydipsia
3) abdominal pain
4) nausea
5) vomiting
6) anorexia
7) weight loss
8) weakness
Diabetic Ketoacidosis - Signs (5)
1) acute onset (<1 week)
2) Kussmaul’s breathing (deep, laboured breathing)
3) tachycardia
4) hypotension
5) dehydrated
Diabetic Ketoacidosis - Complications (6)
1) acute respiratory distress syndrome
2) aspiration pneumonia
3) thromboembolism
4) hypoglycaemia (insulin)
5) hypokalaemia (insulin)
6) cerebral oedema (rehydration)
Diabetic Ketoacidosis - Investigations (5/0)
initial
1) plasma ketones* (>3mM)
2) random plasma glucose (>13.9mM)
3) ABG (pH<7.3, HCO3-<15mM)
4) UnE
5) serum osmolality
Diabetic Ketoacidosis - Management (1/5/0)
conservative 1) ICU admission medical 1) IV fluids (3L in 1st 3 hours) 2) potassium phosphate (replace electrolytes) 3) sodium bicarbonate (metabolic acidosis) 4) insulin 5) vassopressor (DA/NA)
Hyperosmolar Hyperglycaemic State - Description
highly increased plasma glucose and osmolality without ketosis
Hyperosmolar Hyperglycaemic State - Risk Factors (3)
1) uncontrolled diabetes mellitus (esp. type 2)
2) infection
3) myocardial infarction
Hyperosmolar Hyperglycaemic State - Symptoms (9)
1) altered mental status
2) polyuria
3) polydipsia
4) abdominal pain
5) nausea
6) vomiting
7) anorexia
8) weight loss
9) weakness
Hyperosmolar Hyperglycaemic State - Signs (5)
1) acute onset (<1 week)
2) Kussmaul’s breathing (deep, laboured breathing)
3) tachycardia
4) hypotension
5) dehydration
Hyperosmolar Hyperglycaemic State - Complications (6)
1) acute respiratory distress syndrome
2) aspiration pneumonia
3) thromboembolism
4) hypoglycaemia (insulin)
5) hypokalaemia (insulin)
6) cerebral oedema (rehydration)
Hyperosmolar Hyperglycaemic State - Investigations (5/0)
initial
1) plasma ketones (normal)
2) random plasma glucose (>33.3mM)
3) ABG (pH>7.3, HCO3->15mM)
4) UnE
5) serum osmolality (>320mmol/kg)
Hyperosmolar Hyperglycaemic State - Management (1/4/0)
conservative 1) ICU admission medical 1) IV fluids (1-2L in 1st 3 hours) 2) potassium phosphate (replace electrolytes) 3) insulin 4) vassopressor (DA/NA)
Hypoglycaemia - Description
decreased plasma glucose
Hypoglycaemia - Causes (4)
1) insulin
2) sulphonylurea
3) kidney disease
4) liver disease
Hypoglycaemia - Symptoms (Autonomic) (3)
random plasma glucose <3.8mM
1) sweating
2) palpitations
3) tremor
Hypoglycaemia - Symptoms (Neuroglycopenic) (5)
random plasma glucose <2.8mM
1) confusion
2) drowsiness
3) altered behaviour
4) dysphasia
5) incoordination
Hypoglycaemia - Symptoms (Severe Neuroglycopenic) (2)
random plasma glucose <1.5mM
1) convulsions
2) coma
Hypoglycaemia - Investigations (3/0)
initial
1) random plasma glucose (<3.8mM)
2) RFT
3) LFT
Hypoglycaemia - Management (4/2/0)
conservative
1) adjust medications
2) patient education (recognition, treatment)
3) fast acting carbohydrate (15g) (3x 15 minute intervals)
4) long acting carbohydrate (glucose>4mM)
medical
1) IV glucose (unconscious or refractory)
2) IM glucagon (unconscious or refractory)